Galera Therapeutics Inc (GRTX): A Case For Going Higher

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Galera Therapeutics Inc (GRTX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.0026, or 2.06%, to $0.1286. The Galera Therapeutics Inc has recorded 37,057 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Galera Announces Receipt of Type A Meeting Minutes and Strategic Update.

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $0.13 and fluctuated between $0.1500 as its day high and $0.1191 as its day low. The current market capitalization of Galera Therapeutics Inc is $5.54M. A total of 2.52 million shares were traded on the day, compared to an average of 5.94M shares.

Insider Activity

Insider trades can also provide insight into a stock’s future direction. During the recent three months, GRTX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 4 BUYs and 0 SELLs from insiders. Insiders purchased 131,000 shares during that period but sold 0.

In the most recent transaction, Bachleda Mark bought 11,000 shares of GRTX for 2.25 per share on Mar 16. After the transaction, the Chief Commercial Officer now owns 11,000 company shares. In a previous transaction on Mar 13, Degnan Chris bought 10,000 shares at 1.96 per share. GRTX shares that Chief Financial Officer owns now total 10,000.

Among the insiders who bought shares, Sorensen Mel acquired of 100,000 shares on Mar 10 at a per-share price of $1.68. This resulted in the President and CEO holding 332,044 shares of GRTX after the transaction.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for GRTX in the last 3 months, the mean price target is $0.35 with high estimates of $0.50 and low estimates of $0.25. In terms of 52-week highs and lows, GRTX has a high of $3.59 and a low of $0.09.

As of this writing, GRTX has an earnings estimate of -$0.4 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of -$0.36 per share and a lower estimate of -$0.42. The company reported an EPS of -$0.5 in the last quarter, which was -31.60% lower than expectations of -$0.38.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. GRTX’s latest balance sheet shows that the firm has $71.22M in Cash & Short Term Investments as of fiscal 2021. There were $302.00k in debt and $12.94M in liabilities at the time. Its Book Value Per Share was -$2.62, while its Total Shareholder’s Equity was -$58.00M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GRTX is Buy with a score of 2.75.